Literature DB >> 12537932

Progress in the imaging of the prostate gland.

J P M Sedelaar1, J J M C H de la Rosette, F M J Debruyne.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12537932     DOI： 10.1007/s11934-003-0048-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   2.862


× No keyword cloud information.
  22 in total

1.  MR imaging for prostate cancer staging: beauty or beast?

Authors:  Kent Wallner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-15       Impact factor: 7.038

Review 2.  Prostate cancer staging using imaging.

Authors:  M R Engelbrecht; J O Barentsz; G J Jager; M van der Graaf; A Heerschap; J P Sedelaar; R G Aarnink; J J de la Rosette
Journal:  BJU Int       Date:  2000-07       Impact factor: 5.588

3.  Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results.

Authors:  François Cornud; Thierry Flam; Laurent Chauveinc; Khaled Hamida; Yves Chrétien; Annick Vieillefond; Olivier Hélénon; Jean François Moreau
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 4.  Spectroscopy in prostate cancer: hope or hype?

Authors:  M Roach; J Kurhanewicz; P Carroll
Journal:  Oncology (Williston Park)       Date:  2001-11       Impact factor: 2.990

5.  Directed biopsy during contrast-enhanced sonography of the prostate.

Authors:  Ethan J Halpern; Ferdinand Frauscher; Martin Rosenberg; Leonard G Gomella
Journal:  AJR Am J Roentgenol       Date:  2002-04       Impact factor: 3.959

6.  Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.

Authors:  Ferdinand Frauscher; Andrea Klauser; Hubert Volgger; Ethan J Halpern; Leo Pallwein; Hannes Steiner; Antonius Schuster; Wolfgang Horninger; Hermann Rogatsch; Georg Bartsch
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

7.  Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.

Authors:  Michael J Morris; Timothy Akhurst; Iman Osman; Rodolfo Nunez; Homer Macapinlac; Karen Siedlecki; David Verbel; Lawrence Schwartz; Steven M Larson; Howard I Scher
Journal:  Urology       Date:  2002-06       Impact factor: 2.649

Review 8.  MR imaging of prostate cancer.

Authors:  J J Wong-You-Cheong; T L Krebs
Journal:  Magn Reson Imaging Clin N Am       Date:  2000-11       Impact factor: 2.266

9.  Vascular angiographic asymmetry on three-dimensional transrectal power Doppler ultrasonography in patients with organ-confined prostate cancer.

Authors:  Z F Dobrowolski; J Jaszczynski; T Drewniak; W Habrat; J Kusionowicz
Journal:  BJU Int       Date:  2002-04       Impact factor: 5.588

10.  Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer.

Authors:  Steven J DiBiase; Keya Hosseinzadeh; Rao P Gullapalli; Stephen C Jacobs; Michael J Naslund; Geoffrey N Sklar; Richard B Alexander; Cedric Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.